Ardego Therapeutics, Inc.

New Filing
CIK: 0002138133·Biotechnology·DELAWARE·Filed: Jun 2, 2026
Total Offering

$3,000,000

Amount Sold

$50,000

Investors

1

First Sale

May 13, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2026
Non-Accredited Investors
No

Related Persons

NameRole
ETHAN EUGENE MANN
BEVERLY SUE PACKARD

Company

Ardego Therapeutics, Inc.

207A PERRY PARKWAY, SUITE 6

GAITHERSBURG, MD, 20877

402-980-9184

SEC Filing

0002138133-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free